Chemoinformaics analysis of (E)-1,11-Tridecadiene-3,5,7,9-tetrayne
| Molecular Weight | 164.207 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 6 |
| Exact Molecular Weight | 164.063 | nRing | 0 |
| Solubility: LogS | -4.859 | nHRing | 0 |
| Solubility: LogP | 4.692 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0443 |
| nHD | 0 | BPOL | 8.02566 |
| QED | 0.478 |
| Synth | 4.484 |
| Natural Product Likeliness | 2.432 |
| NR-PPAR-gamma | 0.732 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.835 |
| CACO-2 | -4.161 |
| MDCK | 0.000138845 |
| BBB | 0 |
| PPB | 1.04219 |
| VDSS | 1.137 |
| FU | 0.0286888 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.138 |
| CYP2c19-inh | 0.897 |
| CYP2c19-sub | 0.559 |
| CYP2c9-inh | 0.808 |
| CYP2c9-sub | 0.401 |
| CYP2d6-inh | 0.733 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.833 |
| CYP3a4-sub | 0.315 |
| CL | 9.639 |
| T12 | 0.119 |
| hERG | 0 |
| Ames | 0.401 |
| ROA | 0.898 |
| SkinSen | 0.974 |
| Carcinogencity | 0.359 |
| EI | 0.992 |
| Respiratory | 0.597 |
| NR-Aromatase | 0.967 |
| Antiviral | No |
| Prediction | 0.694038 |